iSpecimen (ISPC) Earnings Date & Reports

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ISPC is expected to report earnings to rise 52.63% to -28 cents per share on October 31

Q3'24

Est.

$-0.29

Q2'24

Beat

by $0.09

Q1'24

Missed

by $0.10

Q4'23

Missed

by $0.10

Q3'23

Beat

by $0.12

The last earnings report on August 06 showed earnings per share of -18 cents, beating the estimate of -28 cents. With 57.70K shares outstanding, the current market capitalization sits at 2.11M.

View a ticker or compare two or three

Compare

ISPC